| 000 | 01109 a2200301 4500 | ||
|---|---|---|---|
| 005 | 20250515023452.0 | ||
| 264 | 0 | _c20060803 | |
| 008 | 200608s 0 0 eng d | ||
| 022 | _a1744-7666 | ||
| 024 | 7 |
_a10.1517/14656566.7.7.837 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrebs, Michael | |
| 245 | 0 | 0 |
_aNeuroprotective agents in schizophrenia and affective disorders. _h[electronic resource] |
| 260 |
_bExpert opinion on pharmacotherapy _cMay 2006 |
||
| 300 |
_a837-48 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMood Disorders _xdrug therapy |
| 650 | 0 | 4 |
_aNeurodegenerative Diseases _xdrug therapy |
| 650 | 0 | 4 |
_aNeuroprotective Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 700 | 1 | _aLeopold, Karolina | |
| 700 | 1 | _aHinzpeter, Axel | |
| 700 | 1 | _aSchaefer, Martin | |
| 773 | 0 |
_tExpert opinion on pharmacotherapy _gvol. 7 _gno. 7 _gp. 837-48 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14656566.7.7.837 _zAvailable from publisher's website |
| 999 |
_c16238318 _d16238318 |
||